AcelRx Pharmaceuticals Inc (ACRX) Insider Trading
- $24,584,582.47
- $22,668,088.44
- Dec. 13, 2023
- Mark G Edwards
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 13, 2023 | CEO | 10,000 | $0.73 | Buy | $7,300.00 | |
Sept. 11, 2023 | CEO | 10,000 | $0.80 | Buy | $8,000.00 | |
Aug. 24, 2023 | Insider | 9,514 | $1.17 | Sell | $11,131.38 | |
June 7, 2022 | CEO | 46,400 | $0.22 | Buy | $10,208.00 | |
June 15, 2020 | Director | 100,000 | $1.33 | Buy | $133,000.00 | |
June 15, 2020 | CEO | 7,547 | $1.33 | Buy | $10,037.51 | |
Nov. 12, 2019 | Director | 25,000 | $1.78 | Buy | $44,500.00 | |
Nov. 11, 2019 | CEO | 8,379 | $1.79 | Buy | $14,998.41 | |
Aug. 26, 2019 | Director | 15,000 | $2.19 | Buy | $32,850.00 | |
Aug. 23, 2019 | Director | 10,000 | $2.20 | Buy | $22,000.00 | |
June 5, 2019 | CEO | 5,000 | $2.31 | Buy | $11,550.00 | |
March 12, 2019 | Director | 19,000 | $2.99 | Buy | $56,810.00 | |
Feb. 28, 2019 | CEO | 3,234 | $2.81 | Buy | $9,087.54 | |
Feb. 28, 2019 | CFO | 3,647 | $2.81 | Buy | $10,248.07 | |
Feb. 28, 2019 | Insider | 840 | $2.81 | Buy | $2,360.40 | |
Dec. 14, 2018 | CFO | 5,000 | $2.78 | Buy | $13,900.00 | |
Dec. 14, 2018 | CEO | 3,610 | $2.78 | Buy | $10,035.80 | |
Dec. 12, 2018 | CEO | 10,000 | $2.99 | Buy | $29,900.00 | |
Nov. 19, 2018 | Insider | 16,000 | $3.07 | Buy | $49,120.00 | |
Nov. 15, 2018 | Director | 20,700 | $2.82 | Buy | $58,374.00 | |
Nov. 13, 2018 | CFO | 5,000 | $3.13 | Buy | $15,650.00 | |
Oct. 15, 2018 | Insider | 28,351 | $5.00 | Sell | $141,755.00 | |
Sept. 24, 2018 | Insider | 6,953 | $4.50 | Sell | $31,288.50 | |
Aug. 7, 2018 | CEO | 10,000 | $2.90 | Buy | $29,000.00 | |
Aug. 7, 2018 | Director | 5,300 | $2.84 | Buy | $15,052.00 | |
Aug. 6, 2018 | CFO | 5,000 | $2.75 | Buy | $13,750.00 | |
Aug. 6, 2018 | Insider | 37,000 | $2.75 | Buy | $101,750.00 | |
June 5, 2018 | Director | 5,000 | $3.35 | Buy | $16,750.00 | |
June 1, 2018 | Director | 300 | $3.30 | Buy | $990.00 | |
May 25, 2018 | CFO | 5,000 | $3.18 | Buy | $15,900.00 | |
Nov. 14, 2017 | Director | 30,000 | $1.90 | Buy | $57,000.00 | |
Nov. 13, 2017 | CFO | 5,000 | $1.94 | Buy | $9,700.00 | |
Oct. 2, 2017 | Insider | 10,161 | $5.29 | Sell | $53,751.69 | |
Sept. 11, 2017 | CFO | 7,000 | $3.24 | Buy | $22,680.00 | |
Aug. 24, 2017 | CEO | 15,000 | $3.00 | Buy | $45,000.00 | |
Aug. 24, 2017 | Director | 5,000 | $3.02 | Buy | $15,100.00 | |
Aug. 22, 2017 | Insider | 10,000 | $2.95 | Buy | $29,500.00 | |
June 19, 2017 | Major Shareholder | 875,000 | $2.40 | Sell | $2,100,000.00 | |
Sept. 29, 2016 | Major Shareholder | 216,500 | $3.92 | Sell | $848,680.00 | |
Sept. 15, 2016 | Major Shareholder | 392,850 | $3.70 | Sell | $1,453,545.00 | |
May 13, 2016 | CEO | 10,206 | $3.26 | Buy | $33,271.56 | |
May 12, 2016 | Director | 15,000 | $3.15 | Buy | $47,250.00 | |
Nov. 18, 2015 | Major Shareholder | 176,200 | $5.35 | Sell | $942,670.00 | |
Nov. 6, 2015 | Major Shareholder | 92,100 | $4.59 | Sell | $422,739.00 | |
Sept. 9, 2015 | Major Shareholder | 310,000 | $4.18 | Sell | $1,295,800.00 | |
May 7, 2015 | Director | 40,000 | $3.13 | Buy | $125,200.00 | |
March 10, 2014 | Director | 1,000,000 | $12.35 | Sell | $12,350,000.00 | |
Nov. 7, 2013 | major shareholder | 200,000 | $6.51 | Buy | $1,302,000.00 | |
Nov. 4, 2013 | major shareholder | 155,000 | $6.87 | Buy | $1,064,850.00 | |
Nov. 1, 2013 | Major Shareholder | 360,660 | $6.91 | Buy | $2,492,160.60 |
Insiders are both buying and selling AcelRx Pharmaceuticals Inc stock.
The insider traders at AcelRx Pharmaceuticals Inc are: Mark G Edwards, Perceptive Advisors Llc, Vincent J Angotti, Raffi Asadorian, Pamela P Palmer, Vincent J. Angotti, Guy Nohra, Lawrence G Hamel, Pamela P. Palmer, Adrian Adams, Badri N Dasu, Life Sciences Maste Perceptive, Howard B Rosen, Mark Wan, and Mark A Wan
The most active insider trader at AcelRx Pharmaceuticals Inc is Mark G Edwards with 13 trades.
Mark Wan has sold the most AcelRx Pharmaceuticals Inc stock with a total value of $24,700,000.00.
Perceptive Advisors Llc has bought the most AcelRx Pharmaceuticals Inc stock with a total value of $16,063,510.60.
The most recent insider trade for AcelRx Pharmaceuticals Inc was on Dec. 13, 2023.
The single biggest insider buy for AcelRx Pharmaceuticals Inc was from Perceptive Advisors Llc with a total value of $9,902,500.00 on July 23, 2013.
The single biggest insider sell for AcelRx Pharmaceuticals Inc was from Mark Wan with a total value of $12,350,000.00 on March 10, 2014.